| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |